The World Council of Churches-Ecumenical Advocacy Alliance welcomes an agreement between the Medicines Patent Pool, the Government of South Africa and Abbvie, a research-based biopharmaceutical company, to work together to overcome supply challenges relating to second-line HIV and AIDS treatments lopinavir and ritonavir (LPV/r) in South Africa.
When a WCC meeting on ecumenical HIV and AIDS response concluded last week in Limuru, Kenya, its message to the global HIV and AIDS community was terse: traditional ways of tackling the pandemic have failed.
The idea that HIV is present in the life of every human being, regardless of their susceptibility to the disease, could be seen as shocking. It could even be offensive.
